引導式測驗 · 中等 等級
結核病篩檢之 AI 應用測驗
測試 WHO CAD 篩檢指南、年齡範圍、篩檢與診斷、確認途徑和當地結核病品質監測。
問題 1 的 8
In the WHO screening pathway, what does CAD contribute before diagnostic testing?
預覽每個問題8 問題
當您參加測驗時,就會出現答案和解釋。
- In the WHO screening pathway, what does CAD contribute before diagnostic testing?
- Replace treatment services after a positive score
- Screen every child and adult under the same recommendation
- Help interpret chest X-rays and identify people for further evaluation
- Confirm TB diagnosis without additional testing
- Which age scope did WHO’s 2025 CAD statement address?
- Children younger than 15 only
- People aged 15 years and older, with no recommendation for younger children
- Only infants under one year
- Every age group with the same performance claim
- What should follow a positive CAD screening result?
- A final diagnosis from the score alone
- Treatment chosen automatically by the algorithm
- No follow-up unless a second AI tool agrees
- Confirmatory diagnostic evaluation under the local TB program
- How should an unreadable chest X-ray be interpreted?
- As a test that needs the program’s repeat or referral process
- As negative for TB
- As proof the patient has TB
- As a reason to bypass confirmatory testing
- What should a program monitor after deploying TB CAD?
- Whether the model score is displayed in color
- Image quality, threshold performance, referrals, and confirmatory-test completion
- Only how fast the software opens
- Only the total number of images uploaded
- Why can a CAD threshold need local evaluation?
- Thresholds never affect screening results
- Every population has identical disease prevalence
- The threshold determines which chest X-ray machine is used
- Disease prevalence and population characteristics can change the balance of missed cases and referrals
- What does a low CAD score establish?
- Only that the software did not cross its screening threshold for that image
- That active TB is impossible
- That a person with symptoms never needs evaluation
- That the image was technically perfect
- Why should programs use current WHO product guidance?
- A historical benchmark covers every new device
- A model update automatically guarantees improved performance
- The evaluated products and recommendations can change as evidence and software versions change
- The first product ever evaluated remains approved for all settings